Scientific Name: Tucatinib
Brand Name: Tukysa
Company Owner: Not Available
Mechanism Of Action Mutations in the HER-2 gene are observed in some types of breast carcinoma. Tucatinib inhibits the tyrosine kinase enzyme of the HER-2 gene.
Description of the Drug: Tucatinib is a kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from